Pre-order Enquiry
Request Free Sample
Global Ipilimumab Market Research Report 2022
SKU ID : QYR-21414706 | Publishing Date : 03-Aug-2022 | No. of pages : 86
Detailed TOC of Global Ipilimumab Market Research Report 2022
1 Ipilimumab Market Overview1.1 Product Overview and Scope of Ipilimumab
1.2 Ipilimumab Segment by Type
1.2.1 Global Ipilimumab Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 PD - L1 Antagonists
1.2.3 CTLA4 Antagonists
1.2.4 Immunocheckpoint Inhibitors
1.2.5 Other
1.3 Ipilimumab Segment by Application
1.3.1 Global Ipilimumab Sales Comparison by Application: (2022-2028)
1.3.2 Cancer
1.3.3 Melanoma
1.4 Global Ipilimumab Market Size Estimates and Forecasts
1.4.1 Global Ipilimumab Revenue 2017-2028
1.4.2 Global Ipilimumab Sales 2017-2028
1.4.3 Ipilimumab Market Size by Region: 2017 Versus 2021 Versus 2028
2 Ipilimumab Market Competition by Manufacturers
2.1 Global Ipilimumab Sales Market Share by Manufacturers (2017-2022)
2.2 Global Ipilimumab Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Ipilimumab Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Ipilimumab Manufacturing Sites, Area Served, Product Type
2.5 Ipilimumab Market Competitive Situation and Trends
2.5.1 Ipilimumab Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Ipilimumab Players Market Share by Revenue
2.5.3 Global Ipilimumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ipilimumab Retrospective Market Scenario by Region
3.1 Global Ipilimumab Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Ipilimumab Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Ipilimumab Market Facts & Figures by Country
3.3.1 North America Ipilimumab Sales by Country
3.3.2 North America Ipilimumab Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Ipilimumab Market Facts & Figures by Country
3.4.1 Europe Ipilimumab Sales by Country
3.4.2 Europe Ipilimumab Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Ipilimumab Market Facts & Figures by Region
3.5.1 Asia Pacific Ipilimumab Sales by Region
3.5.2 Asia Pacific Ipilimumab Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Ipilimumab Market Facts & Figures by Country
3.6.1 Latin America Ipilimumab Sales by Country
3.6.2 Latin America Ipilimumab Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Ipilimumab Market Facts & Figures by Country
3.7.1 Middle East and Africa Ipilimumab Sales by Country
3.7.2 Middle East and Africa Ipilimumab Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Ipilimumab Historic Market Analysis by Type
4.1 Global Ipilimumab Sales Market Share by Type (2017-2022)
4.2 Global Ipilimumab Revenue Market Share by Type (2017-2022)
4.3 Global Ipilimumab Price by Type (2017-2022)
5 Global Ipilimumab Historic Market Analysis by Application
5.1 Global Ipilimumab Sales Market Share by Application (2017-2022)
5.2 Global Ipilimumab Revenue Market Share by Application (2017-2022)
5.3 Global Ipilimumab Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Gilead
6.1.1 Gilead Corporation Information
6.1.2 Gilead Description and Business Overview
6.1.3 Gilead Ipilimumab Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Gilead Ipilimumab Product Portfolio
6.1.5 Gilead Recent Developments/Updates
6.2 BMS
6.2.1 BMS Corporation Information
6.2.2 BMS Description and Business Overview
6.2.3 BMS Ipilimumab Sales, Revenue and Gross Margin (2017-2022)
6.2.4 BMS Ipilimumab Product Portfolio
6.2.5 BMS Recent Developments/Updates
6.3 Ono
6.3.1 Ono Corporation Information
6.3.2 Ono Description and Business Overview
6.3.3 Ono Ipilimumab Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Ono Ipilimumab Product Portfolio
6.3.5 Ono Recent Developments/Updates
6.4 Roche
6.4.1 Roche Corporation Information
6.4.2 Roche Description and Business Overview
6.4.3 Roche Ipilimumab Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Roche Ipilimumab Product Portfolio
6.4.5 Roche Recent Developments/Updates
6.5 Prestige BioPharma
6.5.1 Prestige BioPharma Corporation Information
6.5.2 Prestige BioPharma Description and Business Overview
6.5.3 Prestige BioPharma Ipilimumab Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Prestige BioPharma Ipilimumab Product Portfolio
6.5.5 Prestige BioPharma Recent Developments/Updates
6.6 Avacta
6.6.1 Avacta Corporation Information
6.6.2 Avacta Description and Business Overview
6.6.3 Avacta Ipilimumab Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Avacta Ipilimumab Product Portfolio
6.6.5 Avacta Recent Developments/Updates
6.7 Baxter
6.6.1 Baxter Corporation Information
6.6.2 Baxter Description and Business Overview
6.6.3 Baxter Ipilimumab Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Baxter Ipilimumab Product Portfolio
6.7.5 Baxter Recent Developments/Updates
6.8 Shenyang Sansheng Pharmaceutical
6.8.1 Shenyang Sansheng Pharmaceutical Corporation Information
6.8.2 Shenyang Sansheng Pharmaceutical Description and Business Overview
6.8.3 Shenyang Sansheng Pharmaceutical Ipilimumab Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Shenyang Sansheng Pharmaceutical Ipilimumab Product Portfolio
6.8.5 Shenyang Sansheng Pharmaceutical Recent Developments/Updates
7 Ipilimumab Manufacturing Cost Analysis
7.1 Ipilimumab Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Ipilimumab
7.4 Ipilimumab Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Ipilimumab Distributors List
8.3 Ipilimumab Customers
9 Ipilimumab Market Dynamics
9.1 Ipilimumab Industry Trends
9.2 Ipilimumab Market Drivers
9.3 Ipilimumab Market Challenges
9.4 Ipilimumab Market Restraints
10 Global Market Forecast
10.1 Ipilimumab Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Ipilimumab by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Ipilimumab by Type (2023-2028)
10.2 Ipilimumab Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Ipilimumab by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Ipilimumab by Application (2023-2028)
10.3 Ipilimumab Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Ipilimumab by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Ipilimumab by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Figures, Tables and Charts Available in Global Ipilimumab Market Research Report 2022
List of TablesTable 1. Global Ipilimumab Sales Growth Rate Comparison by Type (2022-2028) & (KG) & (US$ Million)
Table 2. Global Ipilimumab Sales Growth Rate Comparison by Application (2022-2028) & (KG) & (US$ Million)
Table 3. Global Ipilimumab Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Ipilimumab Market Competitive Situation by Manufacturers in 2021
Table 5. Global Ipilimumab Sales (KG) of Key Manufacturers (2017-2022)
Table 6. Global Ipilimumab Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Ipilimumab Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Ipilimumab Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Ipilimumab Average Price (US$/G) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Ipilimumab Manufacturing Sites and Area Served
Table 11. Manufacturers Ipilimumab Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Ipilimumab by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ipilimumab as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Ipilimumab Sales by Region (2017-2022) & (KG)
Table 16. Global Ipilimumab Sales Market Share by Region (2017-2022)
Table 17. Global Ipilimumab Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Ipilimumab Revenue Market Share by Region (2017-2022)
Table 19. North America Ipilimumab Sales by Country (2017-2022) & (KG)
Table 20. North America Ipilimumab Sales Market Share by Country (2017-2022)
Table 21. North America Ipilimumab Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Ipilimumab Revenue Market Share by Country (2017-2022)
Table 23. Europe Ipilimumab Sales by Country (2017-2022) & (KG)
Table 24. Europe Ipilimumab Sales Market Share by Country (2017-2022)
Table 25. Europe Ipilimumab Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Ipilimumab Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Ipilimumab Sales by Region (2017-2022) & (KG)
Table 28. Asia Pacific Ipilimumab Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Ipilimumab Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Ipilimumab Revenue Market Share by Region (2017-2022)
Table 31. Latin America Ipilimumab Sales by Country (2017-2022) & (KG)
Table 32. Latin America Ipilimumab Sales Market Share by Country (2017-2022)
Table 33. Latin America Ipilimumab Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Ipilimumab Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Ipilimumab Sales by Country (2017-2022) & (KG)
Table 36. Middle East and Africa Ipilimumab Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Ipilimumab Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Ipilimumab Revenue Market Share by Country (2017-2022)
Table 39. Global Ipilimumab Sales by Type (2017-2022) & (KG)
Table 40. Global Ipilimumab Sales Market Share by Type (2017-2022)
Table 41. Global Ipilimumab Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Ipilimumab Revenue Share by Type (2017-2022)
Table 43. Global Ipilimumab Price by Type (2017-2022) & (US$/G)
Table 44. Global Ipilimumab Sales (KG) by Application (2017-2022)
Table 45. Global Ipilimumab Sales Market Share by Application (2017-2022)
Table 46. Global Ipilimumab Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Ipilimumab Revenue Share by Application (2017-2022)
Table 48. Global Ipilimumab Price by Application (2017-2022) & (US$/G)
Table 49. Gilead Corporation Information
Table 50. Gilead Description and Business Overview
Table 51. Gilead Ipilimumab Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 52. Gilead Ipilimumab Product
Table 53. Gilead Recent Developments/Updates
Table 54. BMS Corporation Information
Table 55. BMS Description and Business Overview
Table 56. BMS Ipilimumab Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 57. BMS Ipilimumab Product
Table 58. BMS Recent Developments/Updates
Table 59. Ono Corporation Information
Table 60. Ono Description and Business Overview
Table 61. Ono Ipilimumab Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 62. Ono Ipilimumab Product
Table 63. Ono Recent Developments/Updates
Table 64. Roche Corporation Information
Table 65. Roche Description and Business Overview
Table 66. Roche Ipilimumab Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 67. Roche Ipilimumab Product
Table 68. Roche Recent Developments/Updates
Table 69. Prestige BioPharma Corporation Information
Table 70. Prestige BioPharma Description and Business Overview
Table 71. Prestige BioPharma Ipilimumab Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 72. Prestige BioPharma Ipilimumab Product
Table 73. Prestige BioPharma Recent Developments/Updates
Table 74. Avacta Corporation Information
Table 75. Avacta Description and Business Overview
Table 76. Avacta Ipilimumab Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 77. Avacta Ipilimumab Product
Table 78. Avacta Recent Developments/Updates
Table 79. Baxter Corporation Information
Table 80. Baxter Description and Business Overview
Table 81. Baxter Ipilimumab Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 82. Baxter Ipilimumab Product
Table 83. Baxter Recent Developments/Updates
Table 84. Shenyang Sansheng Pharmaceutical Corporation Information
Table 85. Shenyang Sansheng Pharmaceutical Description and Business Overview
Table 86. Shenyang Sansheng Pharmaceutical Ipilimumab Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 87. Shenyang Sansheng Pharmaceutical Ipilimumab Product
Table 88. Shenyang Sansheng Pharmaceutical Recent Developments/Updates
Table 89. Production Base and Market Concentration Rate of Raw Material
Table 90. Key Suppliers of Raw Materials
Table 91. Ipilimumab Distributors List
Table 92. Ipilimumab Customers List
Table 93. Ipilimumab Market Trends
Table 94. Ipilimumab Market Drivers
Table 95. Ipilimumab Market Challenges
Table 96. Ipilimumab Market Restraints
Table 97. Global Ipilimumab Sales Forecast by Type (2023-2028) & (KG)
Table 98. Global Ipilimumab Sales Market Share Forecast by Type (2023-2028)
Table 99. Global Ipilimumab Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 100. Global Ipilimumab Revenue Market Share Forecast by Type (2023-2028)
Table 101. Global Ipilimumab Sales Forecast by Application (2023-2028) & (KG)
Table 102. Global Ipilimumab Sales Market Share Forecast by Application (2023-2028)
Table 103. Global Ipilimumab Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 104. Global Ipilimumab Revenue Market Share Forecast by Application (2023-2028)
Table 105. Global Ipilimumab Sales Forecast by Region (2023-2028) & (KG)
Table 106. Global Ipilimumab Sales Market Share Forecast by Region (2023-2028)
Table 107. Global Ipilimumab Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 108. Global Ipilimumab Revenue Market Share Forecast by Region (2023-2028)
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Ipilimumab
Figure 2. Global Ipilimumab Market Share by Type in 2021 & 2028
Figure 3. PD - L1 Antagonists Product Picture
Figure 4. CTLA4 Antagonists Product Picture
Figure 5. Immunocheckpoint Inhibitors Product Picture
Figure 6. Other Product Picture
Figure 7. Global Ipilimumab Market Share by Application in 2021 & 2028
Figure 8. Cancer
Figure 9. Melanoma
Figure 10. Global Ipilimumab Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Ipilimumab Market Size (2017-2028) & (US$ Million)
Figure 12. Global Ipilimumab Sales (2017-2028) & (KG)
Figure 13. Ipilimumab Sales Share by Manufacturers in 2021
Figure 14. Global Ipilimumab Revenue Share by Manufacturers in 2021
Figure 15. The Global 5 and 10 Largest Ipilimumab Players: Market Share by Revenue in 2021
Figure 16. Ipilimumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 17. Global Ipilimumab Sales Market Share by Region (2017-2022)
Figure 18. Global Ipilimumab Sales Market Share by Region in 2021
Figure 19. Global Ipilimumab Revenue Market Share by Region (2017-2022)
Figure 20. Global Ipilimumab Revenue Market Share by Region in 2021
Figure 21. U.S. Ipilimumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Canada Ipilimumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Germany Ipilimumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. France Ipilimumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. U.K. Ipilimumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Italy Ipilimumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Russia Ipilimumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. China Ipilimumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Japan Ipilimumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. South Korea Ipilimumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. India Ipilimumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Australia Ipilimumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Taiwan Ipilimumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Indonesia Ipilimumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Thailand Ipilimumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Malaysia Ipilimumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Philippines Ipilimumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Vietnam Ipilimumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Mexico Ipilimumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Brazil Ipilimumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Argentina Ipilimumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Turkey Ipilimumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Saudi Arabia Ipilimumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. UAE Ipilimumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Sales Market Share of Ipilimumab by Type (2017-2022)
Figure 46. Manufacturing Cost Structure of Ipilimumab
Figure 47. Manufacturing Process Analysis of Ipilimumab
Figure 48. Ipilimumab Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Keyplayers in Global Ipilimumab Market Research Report 2022
GileadBMS
Ono
Roche
Prestige BioPharma
Avacta
Baxter
Shenyang Sansheng Pharmaceutical
Request Sample
Request Discount
